Category: Guest content

Guest Post: Biotechnology Patent Trolls

This is a guest post from the BiotechBlog Intern,  Fintan Burke. Fintan is a student at the School of Biotechnology at Dublin City University. Do you have a response to Fintan’s post? Respond in the comments section below. According to a BDO industry report, a smallUS biotech company in 2010 enjoyed average revenues of around […]


Click here for reuse options!
Copyright 2012 Biotechblog

IPO on the Cheap?

This is a guest post by Jurgita Ashley You are a small company ready to take a leap into the public market, whether it is for growth, liquidity or to attract greater investor interest. But, oh man, those dollar figures for IPOs would make anyone’s head spin. But wait, don’t discount it yet as a […]


Click here for reuse options!
Copyright 2011 Biotechblog

Technology Continues to Fight Aids

This is a guest post from BiotechBlog reader Jack Lundee Technology Continues to Fight Aids In 2008, Sub-Saharan Africa was populated with over 22 million HIV+ inhabitants, and currently there are over 5 million Southern Africans infected with the virus. Worldwide, there are upwards of 40 million people infected with HIV, a very frightening number. […]


Click here for reuse options!
Copyright 2010 Biotechblog

Biosimilar drugs to gain greater priority as decade progresses

This is a guest post from Keith Bradbury, Executive Director of Drug Information at Medco Health Solutions, Inc. Biosimilar drugs to gain greater priority as decade progresses The Patient Protection and Affordable Care Act will heighten the degree of competition in the field of biotech drugs, a fast growing area of drug therapy that is […]


Click here for reuse options!
Copyright 2010 Biotechblog

Biotechnology Management Papers, 2010

These papers are from the 2010 final projects in the NIH Foundation for Advanced Education in the Sciences TECH 366 — Biotechnology Management. The students were asked to tell a story based on the course lectures, and to expand with general lessons biotechnology company management: If You Build It, Will They Come? Derek Francis Profitability […]


Click here for reuse options!
Copyright 2010 Biotechblog

Profitability and Orphans: The Role of Price and Incentives in Four Different Markets

This is a student paper from the 2010 final projects in the NIH Foundation for Advanced Education in the Sciences’ TECH 366 — Biotechnology Management. The students were asked to tell a story based on the course lectures, and to expand with general lessons on biotechnology company management. Profitability and Orphans: The Role of Price […]


Click here for reuse options!
Copyright 2010 Biotechblog

If You Build It, Will They Come?

This is a student paper from the 2010 final projects in the NIH Foundation for Advanced Education in the Sciences’ TECH 366 — Biotechnology Management. The students were asked to tell a story based on the course lectures, and to expand with general lessons on biotechnology company management. If You Build It, Will They Come? […]


Click here for reuse options!
Copyright 2010 Biotechblog

Patent Analysis: A Tool for Making Strategic Business Decisions

This is a student paper from the 2010 final projects in the NIH Foundation for Advanced Education in the Sciences’ TECH 366 — Biotechnology Management. The students were asked to tell a story based on the course lectures, and to expand with general lessons on biotechnology company management. Patent Analysis: A Tool for Making Strategic […]


Click here for reuse options!
Copyright 2010 Biotechblog

Guest post: Healthcare Reform Bill Presents Significant Opportunity for Life Science Companies Engaged in Innovative Research

This is a guest post from William H. Kitchens, partner at the Atlanta law firm Arnall Golden Gregory LLP. Do you have a response to Kitchens’ post? Respond in the comments section below. Buried in the recently enacted Patient Protection and Affordable Care Act of 2010 is a significant benefit for small- and mid-sized biotech, […]


Click here for reuse options!
Copyright 2010 Biotechblog

Top 4 Healthcare Predictions for 2010

This is a guest post from Cliff Cramer, Director of the Healthcare and Pharmaceutical Management Program at Columbia Business School. Do you have a response to Cramer’s post? Post them in the comments section below. Multi-national pharmaceutical and medical technology companies will increase their investments in emerging markets, notably China and India, to access cost […]


Click here for reuse options!
Copyright 2009 Biotechblog

%d bloggers like this: